Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 6Glioma 2Brain Neoplasms 2Stroke 1Neurologic Manifestations 1Neoplasms 1Margins of Excision 1Gliosarcoma 1Communication 1Central Nervous System Neoplasms 1Caregiver Burden 1Brain Injuries, Traumatic 1Brain Injuries 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Palliative Care × CNS × Clear all
NCT04630379 2023-03-20

Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers

Mayo Clinic

Phase NA Completed
16 enrolled
CNS

Glioblastoma, Glioma

NCT03471546 2020-11-24

Early Palliative Care Intervention in Malignant Glioma

Duke University

Phase NA Completed
12 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡